Anecortave acetate
- Generic Name
- Anecortave acetate
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H30O5
- CAS Number
- 7753-60-8
- Unique Ingredient Identifier
- Y0PC411K4T
- Background
Anecortave acetate (Retaane) is an analog of cortisol acetate; among the modifications to the steroid are the removal of the 11ร hydroxyl OH group and an addition of a 21-acetate group. As a result of these modifications, anecortave acetate lacks the typical antiinflammatory and immunosuppressive properties of glucocorticoids.Alcon Inc. is developing and mar...
- Indication
Investigated for use/treatment in glaucoma and macular degeneration.
- Associated Conditions
- -
- Associated Therapies
- -
Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients
- Conditions
- Interventions
- First Posted Date
- 2009-04-20
- Last Posted Date
- 2018-08-14
- Lead Sponsor
- Cornea Research Foundation of America
- Target Recruit Count
- 7
- Registration Number
- NCT00884039
- Locations
- ๐บ๐ธ
Price Vision Group, Indianapolis, Indiana, United States
A Multi-Dose Study With a Treatment for Open-Angle Glaucoma
- First Posted Date
- 2008-06-26
- Last Posted Date
- 2012-05-30
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT00705770
Prophylactic Anecortave Acetate in Patients With a Retisert Implant
- First Posted Date
- 2007-12-11
- Last Posted Date
- 2012-06-05
- Lead Sponsor
- Texas Retina Associates
- Target Recruit Count
- 12
- Registration Number
- NCT00570479
- Locations
- ๐บ๐ธ
Texas Retina Associates, Arlington, Texas, United States
Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
- Conditions
- Interventions
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Target Recruit Count
- 5
- Registration Number
- NCT00489840
- Locations
- ๐บ๐ธ
Manhattan Eye, ear & Throat Institute, New York, New York, United States
๐บ๐ธVitreous-Retina-Macula Consultants of New York,PC, New York, New York, United States
Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate
- Conditions
- First Posted Date
- 2006-07-10
- Last Posted Date
- 2010-01-15
- Lead Sponsor
- University of Iowa
- Registration Number
- NCT00349739
- Locations
- ๐บ๐ธ
University of Iowa Hospitals and Clinics, Ophthalmology, Iowa City, Iowa, United States
Anecortave Acetate Versus Placebo in AMD Patients Following PDT
- Conditions
- First Posted Date
- 2006-06-30
- Last Posted Date
- 2008-08-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 136
- Registration Number
- NCT00346866
- Locations
- ๐บ๐ธ
Facility, Beachwood, Ohio, United States
Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2009-02-04
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Registration Number
- NCT00211354
- Locations
- ๐บ๐ธ
Manhattan Eye, Ear & Throat Hospital, New York, New York, United States
Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2009-02-04
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Target Recruit Count
- 5
- Registration Number
- NCT00211328
- Locations
- ๐บ๐ธ
Manhattan Eye, Ear & Throat Hospital, New York, New York, United States
Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2007-06-21
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Target Recruit Count
- 2
- Registration Number
- NCT00211367
- Locations
- ๐บ๐ธ
Manhattan Eye, Ear & Throat Hospital, New York, New York, United States
Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2007-05-07
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Target Recruit Count
- 5
- Registration Number
- NCT00211484
- Locations
- ๐บ๐ธ
Manhattan Eye, Ear & Throat Hospital, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.